RVMD – revolution medicines, inc. (US:NASDAQ)
Stock Stats
News
Ben Sasse was given a few months to live. He credits "providence, prayer and a miracle drug" for giving him more time. [CBS News]
Revolution Medicines (RVMD) had its price target raised by Leerink Partners from $147.00 to $171.00. They now have an "outperform" rating on the stock.
Revolution Medicines (RVMD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $169.00 price target on the stock.
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting
Form 4 Revolution Medicines, For: Apr 15 Filed by: GOLDSMITH MARK A
Form 8-K Revolution Medicines, For: Apr 14
Form 8-K Revolution Medicines, For: Apr 14
Form 424B5 Revolution Medicines,
Form 424B5 Revolution Medicines,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.